Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 5 hours ago
MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization
about 5 hours ago
As MeiraGTx lines up the pieces for a commercial push, the company...
Beckman Coulter grows Alzheimer’s dx portfolio with CE mark for new assay
about 5 hours ago
Diagnostics specialist Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by...
Whitehawk swoops in for five ADCs via development deal with China's Biocytogen
about 8 hours ago
Biocytogen and Whitehawk Therapeutics are joining forces to develop bispecific antibody-drug conjugates...
Endevica spinout Kalohexis submits confidential IPO filing to develop obesity challenger to GLP-1s
about 8 hours ago
Clinical-stage Kalohexis is readying a public listing to support its obesity and...
As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’
about 9 hours ago
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role...
Boehringer bags PVT’s viral vector platform for cancer vaccine R&D
about 9 hours ago
Boehringer Ingelheim has landed an exclusive license to Prime Vector Technologies’ viral...
Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical
about 10 hours ago
As Novo Nordisk looks for new ways to broaden its semaglutide GLP-1...
Kailera’s oral GLP-1 asset sees 11% weight loss, hits goals in Chinese phase 3 obesity and diabetes trials
about 10 hours ago
Phase 3 trials of Kailera Therapeutics’ oral GLP-1 prospect have hit their...
NICE recommends Endosure and Endotest diagnostics for endometriosis
about 11 hours ago
Women in England are set to gain new, taxpayer-funded tests for endometriosis...
Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
about 11 hours ago
Vertex Pharmaceuticals has struck a $10 billion deal—its largest ever—to acquire endocrine...
Scribe notes down IPO ambition to fund lipid-lowering genetic meds through clinical trials
1 day ago
Scribe Therapeutics is the latest biotech to prepare a public listing, as...
Exact Imaging boosts U.S. commercial team for next-gen prostate cancer testing tech
1 day ago
Exact Imaging is looking to broaden uptake of its high-resolution micro-ultrasound system...